Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias
Sleep
.
2021 Apr 9;44(4):zsab019.
doi: 10.1093/sleep/zsab019.
Authors
R Doug McEvoy
1
2
,
Manuel Sánchez-de-la-Torre
3
4
,
Yüksel Peker
5
6
7
8
,
Craig S Anderson
9
10
,
Susan Redline
11
,
Ferran Barbe
4
12
Affiliations
1
Adelaide Institute for Sleep Health, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
2
Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia.
3
Group of Precision Medicine in Chronic Diseases, Hospital Arnau de Vilanova-Santa Maria, IRBLleida, Lleida, Spain.
4
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
5
Department of Pulmonary Medicine, Koc University School of Medicine, Istanbul, Turkey.
6
Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
7
Department of Clinical Sciences, Respiratory Medicine and Allergology, Faculty of Medicine, Lund University, Lund, Sweden.
8
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.
9
The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
10
The George Institute China at Peking University Health Science Center, Beijing, PR China.
11
Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
12
Translation Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova-Santa Maria, IRB Lleida, Lleida, Spain.
PMID:
33693919
PMCID:
PMC8033450
DOI:
10.1093/sleep/zsab019
No abstract available
Publication types
Comment
MeSH terms
Cardiovascular Diseases* / epidemiology
Continuous Positive Airway Pressure
Humans
Randomized Controlled Trials as Topic
Sleep Apnea, Obstructive* / therapy
Grants and funding
R35 HL135818/HL/NHLBI NIH HHS/United States